Unexpected Neurological Symptoms of Ruxolitinib: A Case Report.
Myelofibrosis
Polycythemia vera
Ruxolitinib
Journal
Journal of hematology
ISSN: 1927-1220
Titre abrégé: J Hematol
Pays: Canada
ID NLM: 101635099
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
21
04
2020
accepted:
20
08
2020
entrez:
23
11
2020
pubmed:
24
11
2020
medline:
24
11
2020
Statut:
ppublish
Résumé
Ruxolitinib is a highly potent
Identifiants
pubmed: 33224394
doi: 10.14740/jh642
pmc: PMC7665860
doi:
Types de publication
Case Reports
Langues
eng
Pagination
137-139Informations de copyright
Copyright 2020, Furia et al.
Déclaration de conflit d'intérêts
None to declare.
Références
Leukemia. 2018 May;32(5):1057-1069
pubmed: 29515238
Br J Haematol. 2010 Mar;148(6):961-3
pubmed: 19930182
N Engl J Med. 2015 Jan 29;372(5):426-35
pubmed: 25629741
Br J Haematol. 2019 Nov;187(3):286-295
pubmed: 31468506
Br J Haematol. 2013 Sep;162(6):730-47
pubmed: 23855810
Haematologica. 2016 Jul;101(7):821-9
pubmed: 27102499
Curr Hematol Malig Rep. 2020 Apr;15(2):133-140
pubmed: 32034662
Blood Cancer J. 2015 Nov 13;5:e366
pubmed: 26565403
Am J Hematol. 2008 Jun;83(6):491-7
pubmed: 18429051
N Engl J Med. 2012 Mar 1;366(9):787-98
pubmed: 22375970
Leuk Lymphoma. 2020 Mar;61(3):660-667
pubmed: 31711337
N Engl J Med. 2004 Jan 8;350(2):114-24
pubmed: 14711910
Am J Hematol. 2012 Mar;87(3):285-93
pubmed: 22331582
N Engl J Med. 2013 Jan 3;368(1):22-33
pubmed: 23216616